Found Weight Loss Review: GLP-1 Programs, Pricing & Results
A comprehensive review of Found's weight loss program, including their GLP-1 medication options, behavior change coaching model, pricing structure, and how Found compares to Trimi for patients seeking affordable semaglutide or tirzepatide.
More on GLP-1 Provider Comparisons
Found's Approach: Medication Plus Behavior Change
Found was founded in 2019 with a philosophy that weight loss requires more than just medication — it requires a comprehensive approach that addresses the behavioral, psychological, and environmental factors that contribute to weight gain. This "whole person" approach sets Found apart from many telehealth platforms that focus primarily on prescribing and delivering GLP-1 medications.
At its core, Found's model pairs prescription weight loss medication with dedicated health coaching, a community of fellow patients, and educational content designed to help patients build sustainable habits. The company positions itself not just as a medication delivery platform but as a weight loss program that happens to include medication as one component of a multi-pronged strategy. This approach is grounded in real science — meta-analyses consistently demonstrate that intensive lifestyle interventions combined with pharmacotherapy produce greater and more sustained weight loss than either approach alone.
Found's medication options are not limited to GLP-1 receptor agonists. Their providers evaluate each patient's health profile and may recommend GLP-1 medications like semaglutide or tirzepatide, or they may recommend other pharmacological approaches such as metformin, bupropion-naltrexone (Contrave), topiramate, or other medications depending on the patient's clinical situation, insurance coverage, and treatment goals. This medication flexibility is a genuine advantage for patients whose clinical profiles may not be ideal for GLP-1 therapy or who want to explore less expensive medication options first.
The trade-off with Found's comprehensive approach is cost and complexity. Patients who specifically want affordable, streamlined access to compounded GLP-1 medications without the additional coaching layer may find that the bundled model adds cost without adding the value they are personally seeking. This is an important distinction — Found's coaching is genuinely valuable for many patients, but it is not what every patient needs or wants.
Found's Coaching Model: How It Works
The coaching component is central to Found's value proposition and worth examining in detail. After enrollment, patients are matched with a dedicated health coach who provides regular check-ins, accountability, and personalized guidance on nutrition, exercise, sleep, stress management, and other lifestyle factors that influence weight management outcomes.
Coaching interactions typically happen through the Found app via messaging, with the frequency and depth varying by plan tier. The coaches are trained in behavior change methodologies and work with patients to identify and overcome specific obstacles — whether that is emotional eating patterns, difficulty with meal planning, sedentary work environments, or the psychological challenges that often accompany significant weight loss. This kind of structured support can be transformative for patients who have struggled with weight management on their own.
Found also provides community features where patients can connect with others on similar journeys. The peer support element — sharing experiences, challenges, and successes — adds a social dimension to the weight loss process that pure medication-delivery platforms do not typically offer. Community engagement is a well-documented factor in behavior change maintenance, and Found has invested in building this aspect of their platform.
The honest assessment of Found's coaching model is that it works well for a specific patient profile: someone who benefits from external accountability, wants structured behavioral support, and is willing to pay a premium for a comprehensive program. For patients who are self-motivated, have existing support systems, or primarily need affordable medication access, the coaching component may represent an added cost that does not match their personal needs. Neither approach is right or wrong — it depends entirely on the individual patient.
Evidence for Combination Approaches
Clinical research supports combining medication with lifestyle modification for optimal weight loss outcomes. The STEP trials for semaglutide showed that patients who also received lifestyle counseling had enhanced results. However, the specific coaching model matters — and patients should evaluate whether a particular program's coaching structure matches their learning style and needs.
Found Pricing: Breaking Down the Costs
Found's pricing structure is more complex than straightforward medication-delivery platforms because it bundles coaching, community access, and the technology platform into a base membership fee, with medication costs layered on top. Understanding the total cost is essential for comparing Found to alternatives.
The base Found membership, which covers coaching, community, app access, and provider consultations, has generally been priced in the range of $99 to $149 per month. This fee is charged regardless of which medication you are prescribed. On top of this membership, medication costs vary widely. Patients prescribed lower-cost medications like metformin may pay relatively little for medication itself. Patients prescribed GLP-1 medications like compounded semaglutide will pay significantly more for the medication component, bringing total monthly costs into the range of approximately $199 to $349 or higher.
For comparison, platforms like Trimi that focus specifically on GLP-1 medication delivery typically offer all-inclusive pricing that covers the provider consultation, medication, and ongoing clinical support without a separate membership fee. The result is that patients seeking specifically GLP-1 therapy often find more affordable options through focused platforms than through comprehensive programs that bundle additional services.
It is important to evaluate Found's pricing in terms of what you are actually receiving. If you will actively use the coaching and community features, the additional cost may be justified by the behavioral support. If you are primarily interested in affordable GLP-1 medication access with solid clinical oversight, a focused platform will likely provide better value for your specific needs. The key is honest self-assessment about which services you will actually use.
Medication Options on Found
One of Found's strengths is the breadth of their medication formulary. Unlike platforms that offer only GLP-1 medications, Found's providers can prescribe from a wider range of weight loss pharmacotherapies based on each patient's clinical profile. This flexibility is a genuine advantage for patients who may not be candidates for GLP-1 therapy or who want to explore other medication pathways first.
Found's medication options typically include GLP-1 receptor agonists (semaglutide and potentially tirzepatide depending on availability), metformin (which has modest weight loss effects and can help with insulin resistance), bupropion-naltrexone combinations (which target appetite regulation through different neurological pathways), and other medications that the provider may recommend based on the patient's specific metabolic profile and health history.
For patients specifically seeking GLP-1 therapy, however, Found's multi-medication approach can sometimes feel less focused than platforms built specifically around GLP-1 access. Found's providers may recommend non-GLP-1 medications that they consider more appropriate for a particular patient's situation — which is clinically sound but may not align with patients who have specifically sought out GLP-1 therapy based on their own research and preferences.
Trimi's approach is more targeted: the platform exists specifically to provide affordable access to compounded semaglutide and tirzepatide with providers who specialize in these medications. For patients who know they want GLP-1 therapy, this focused approach eliminates ambiguity and ensures that the entire care experience is optimized around GLP-1 prescribing, dosing, and management. For more about safe access to compounded formulations, see our guide on compounded semaglutide safety.
Pros and Cons of Found Weight Loss
Found: Strengths
Comprehensive approach combining medication with evidence-based behavior change coaching
Dedicated health coach providing personalized accountability and lifestyle guidance
Broad medication formulary beyond just GLP-1 — multiple treatment pathways available
Community support features that add a social and motivational dimension to treatment
Good fit for patients who benefit from structured programs and external accountability
Providers evaluate full metabolic health picture, not just GLP-1 eligibility
Found: Limitations
Higher total cost due to mandatory membership fee on top of medication costs
Coaching may not add value for self-motivated patients who primarily want medication access
GLP-1 availability may vary — not all patients receive GLP-1 prescriptions through the program
Multi-medication approach means you may be prescribed a non-GLP-1 medication even if you sought GLP-1 specifically
More complex pricing structure makes it harder to compare costs with other platforms at a glance
Found vs. Trimi: Who Is Each Platform Best For?
The choice between Found and Trimi comes down to what kind of weight loss experience you are looking for and how you define value in a healthcare relationship.
Found is likely the better fit if you value a comprehensive, coached weight loss program and are willing to pay more for structured behavioral support. If you are unsure whether GLP-1 therapy is right for you and want a provider to evaluate you for multiple medication options, Found's broad formulary is an advantage. If you have struggled with weight loss in the past and believe that coaching and community support would help you stay on track, Found's model is designed exactly for that need.
Trimi is likely the better fit if you have done your research, know you want GLP-1 therapy, and want the most affordable and streamlined path to compounded semaglutide or tirzepatide. If you are self-motivated and do not feel you need external coaching to adhere to your treatment, Trimi eliminates the cost of services you would not use. If you want providers who specialize specifically in GLP-1 prescribing and management, Trimi's focused model delivers depth of expertise in that specific area. Trimi's transparent pricing also makes it easy to budget for long-term treatment.
There is no wrong choice between these platforms — they serve different patient needs authentically. The key is matching the platform to your actual needs rather than paying for features you will not use or skipping support that would genuinely help you succeed. For more options and an overview of costs across the GLP-1 landscape, review our guide on the cost of semaglutide treatment.
Frequently Asked Questions
What is Found weight loss?
Found is a telehealth weight loss platform that combines prescription medication with behavior change coaching and community support. Founded in 2019, the company takes a comprehensive approach that goes beyond just prescribing medication. Their model includes a health assessment, provider consultation, ongoing coaching from a dedicated health coach, access to a community of other patients, and educational content. Found offers various medication options including GLP-1 receptor agonists, as well as other weight loss medications like metformin and bupropion-naltrexone combinations depending on the patient's clinical profile.
How much does Found cost per month?
Found's pricing structure includes a base membership fee plus the cost of medication. The membership fee, which covers coaching, community access, and the technology platform, has generally been in the range of $99 to $149 per month. Medication costs are additional and vary significantly depending on what is prescribed — GLP-1 medications will cost more than medications like metformin or bupropion-naltrexone. Total monthly costs for patients on GLP-1 therapy through Found can range from approximately $199 to $349 or more depending on the specific medication and dose. Always verify current pricing directly on Found's website.
Does Found prescribe semaglutide?
Yes, Found offers semaglutide as one of several medication options in their weight loss program. Their providers evaluate each patient's health profile and may recommend semaglutide, tirzepatide, or other medications based on clinical appropriateness. Found has offered both compounded and, depending on availability, pathways toward brand-name GLP-1 medications. The specific medications available through Found may vary based on current supply, regulatory conditions, and the patient's individual clinical needs as assessed by their provider.
Is Found's coaching worth the extra cost?
Found's coaching model adds value for patients who benefit from structured accountability, behavioral support, and community motivation. Research consistently shows that combining medication with lifestyle modification produces better long-term outcomes than medication alone. However, the question is whether the specific coaching model justifies the additional cost for you. Some patients thrive with dedicated coaching support, while others prefer a more streamlined, medication-focused approach and may find equivalent behavioral support through other resources. If structured coaching is important to your success, Found's model may be worth the investment. If you prefer affordable, direct medication access, a focused platform may be more cost-effective.
Can I switch from Found to Trimi?
Yes, switching from Found to Trimi is straightforward. Complete Trimi's health assessment, share your current medication and dosage information, and a Trimi provider will evaluate your history and can typically continue your treatment without interruption. Many patients who switch from Found to Trimi do so because they want more affordable GLP-1 access without the bundled coaching fees. Plan the transition to avoid any gap between your last Found shipment and your first Trimi delivery.
Does Found offer tirzepatide?
Found has expanded its GLP-1 offerings over time and may offer tirzepatide depending on current availability and regulatory conditions. Found's providers consider multiple medication options for each patient, so tirzepatide availability may depend on your specific clinical profile and what the platform is currently offering. Trimi offers both compounded semaglutide and compounded tirzepatide as standard options, providing consistent access to both major GLP-1 molecules regardless of broader supply fluctuations.
What makes Found different from other weight loss platforms?
Found's primary differentiator is its emphasis on behavior change alongside medication. While most telehealth GLP-1 platforms focus primarily on prescribing and fulfilling medication, Found wraps a coaching and community experience around the prescription. Their approach is rooted in the evidence that sustainable weight loss requires both pharmacological and behavioral interventions. The trade-off is that this comprehensive approach typically comes at a higher total cost than medication-focused platforms. For patients who want the most affordable path to GLP-1 medications specifically, a focused platform like Trimi may be more appropriate.
Sources & References
- Found Health, Inc. Official Website and Program Information. 2026.
- Wadden TA, et al. "Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight." JAMA, 2021;325(14):1403-1413.
- Wilding JPH, et al. "Once-weekly semaglutide in adults with overweight or obesity." NEJM, 2021;384:989-1002.
- Jastreboff AM, et al. "Tirzepatide once weekly for the treatment of obesity." NEJM, 2022;387:205-216.
- Jensen MD, et al. "AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults." Circulation, 2014;129(25 Suppl 2):S102-S138.
- FDA. "Compounding and the FDA: Questions and Answers." U.S. Food and Drug Administration, 2025.
- Novo Nordisk. Wegovy (semaglutide) Prescribing Information. 2024.
- Rubino DM, et al. "Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight." JAMA, 2022;327(2):138-150.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Pricing and availability information is approximate and subject to change. This article was prepared by the Trimi Medical Team and naturally reflects our perspective, though we have made every effort to present competitor information fairly and accurately.